Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
8,265
archived clinical trials in
Rheumatoid Arthritis

A Study in Participants With Moderate to Severe Rheumatoid Arthritis
A Randomized, Double-Blind, Active-Controlled,Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib (LY3009104) in Patients With Moderately to Severely Active Rheumatoid Arthritis Who Have Had Limited or No Treatment With Disease-Modifying Antirheumatic Drugs
Status: Enrolling
Updated:  9/24/2015
Clinical Research Facility
mi
from
Plantation, FL
A Study in Participants With Moderate to Severe Rheumatoid Arthritis
A Randomized, Double-Blind, Active-Controlled,Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib (LY3009104) in Patients With Moderately to Severely Active Rheumatoid Arthritis Who Have Had Limited or No Treatment With Disease-Modifying Antirheumatic Drugs
Status: Enrolling
Updated: 9/24/2015
Clinical Research Facility
mi
from
Plantation, FL
Click here to add this to my saved trials
A Study in Participants With Moderate to Severe Rheumatoid Arthritis
A Randomized, Double-Blind, Active-Controlled,Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib (LY3009104) in Patients With Moderately to Severely Active Rheumatoid Arthritis Who Have Had Limited or No Treatment With Disease-Modifying Antirheumatic Drugs
Status: Enrolling
Updated:  9/24/2015
Clinical Research Facility
mi
from
Tampa, FL
A Study in Participants With Moderate to Severe Rheumatoid Arthritis
A Randomized, Double-Blind, Active-Controlled,Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib (LY3009104) in Patients With Moderately to Severely Active Rheumatoid Arthritis Who Have Had Limited or No Treatment With Disease-Modifying Antirheumatic Drugs
Status: Enrolling
Updated: 9/24/2015
Clinical Research Facility
mi
from
Tampa, FL
Click here to add this to my saved trials
A Study in Participants With Moderate to Severe Rheumatoid Arthritis
A Randomized, Double-Blind, Active-Controlled,Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib (LY3009104) in Patients With Moderately to Severely Active Rheumatoid Arthritis Who Have Had Limited or No Treatment With Disease-Modifying Antirheumatic Drugs
Status: Enrolling
Updated:  9/24/2015
Clinical Research Facility
mi
from
Venice, FL
A Study in Participants With Moderate to Severe Rheumatoid Arthritis
A Randomized, Double-Blind, Active-Controlled,Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib (LY3009104) in Patients With Moderately to Severely Active Rheumatoid Arthritis Who Have Had Limited or No Treatment With Disease-Modifying Antirheumatic Drugs
Status: Enrolling
Updated: 9/24/2015
Clinical Research Facility
mi
from
Venice, FL
Click here to add this to my saved trials
A Study in Participants With Moderate to Severe Rheumatoid Arthritis
A Randomized, Double-Blind, Active-Controlled,Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib (LY3009104) in Patients With Moderately to Severely Active Rheumatoid Arthritis Who Have Had Limited or No Treatment With Disease-Modifying Antirheumatic Drugs
Status: Enrolling
Updated:  9/24/2015
Clinical Research Facility
mi
from
Vernon Hills, IL
A Study in Participants With Moderate to Severe Rheumatoid Arthritis
A Randomized, Double-Blind, Active-Controlled,Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib (LY3009104) in Patients With Moderately to Severely Active Rheumatoid Arthritis Who Have Had Limited or No Treatment With Disease-Modifying Antirheumatic Drugs
Status: Enrolling
Updated: 9/24/2015
Clinical Research Facility
mi
from
Vernon Hills, IL
Click here to add this to my saved trials
A Study in Participants With Moderate to Severe Rheumatoid Arthritis
A Randomized, Double-Blind, Active-Controlled,Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib (LY3009104) in Patients With Moderately to Severely Active Rheumatoid Arthritis Who Have Had Limited or No Treatment With Disease-Modifying Antirheumatic Drugs
Status: Enrolling
Updated:  9/24/2015
Clinical Research Facility
mi
from
Indianapolis, IN
A Study in Participants With Moderate to Severe Rheumatoid Arthritis
A Randomized, Double-Blind, Active-Controlled,Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib (LY3009104) in Patients With Moderately to Severely Active Rheumatoid Arthritis Who Have Had Limited or No Treatment With Disease-Modifying Antirheumatic Drugs
Status: Enrolling
Updated: 9/24/2015
Clinical Research Facility
mi
from
Indianapolis, IN
Click here to add this to my saved trials
A Study in Participants With Moderate to Severe Rheumatoid Arthritis
A Randomized, Double-Blind, Active-Controlled,Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib (LY3009104) in Patients With Moderately to Severely Active Rheumatoid Arthritis Who Have Had Limited or No Treatment With Disease-Modifying Antirheumatic Drugs
Status: Enrolling
Updated:  9/24/2015
Clinical Research Facility
mi
from
Cumberland, MD
A Study in Participants With Moderate to Severe Rheumatoid Arthritis
A Randomized, Double-Blind, Active-Controlled,Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib (LY3009104) in Patients With Moderately to Severely Active Rheumatoid Arthritis Who Have Had Limited or No Treatment With Disease-Modifying Antirheumatic Drugs
Status: Enrolling
Updated: 9/24/2015
Clinical Research Facility
mi
from
Cumberland, MD
Click here to add this to my saved trials
A Study in Participants With Moderate to Severe Rheumatoid Arthritis
A Randomized, Double-Blind, Active-Controlled,Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib (LY3009104) in Patients With Moderately to Severely Active Rheumatoid Arthritis Who Have Had Limited or No Treatment With Disease-Modifying Antirheumatic Drugs
Status: Enrolling
Updated:  9/24/2015
Clinical Research Facility
mi
from
Grand Rapids, MI
A Study in Participants With Moderate to Severe Rheumatoid Arthritis
A Randomized, Double-Blind, Active-Controlled,Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib (LY3009104) in Patients With Moderately to Severely Active Rheumatoid Arthritis Who Have Had Limited or No Treatment With Disease-Modifying Antirheumatic Drugs
Status: Enrolling
Updated: 9/24/2015
Clinical Research Facility
mi
from
Grand Rapids, MI
Click here to add this to my saved trials
A Study in Participants With Moderate to Severe Rheumatoid Arthritis
A Randomized, Double-Blind, Active-Controlled,Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib (LY3009104) in Patients With Moderately to Severely Active Rheumatoid Arthritis Who Have Had Limited or No Treatment With Disease-Modifying Antirheumatic Drugs
Status: Enrolling
Updated:  9/24/2015
Clinical Research Facility
mi
from
Lansing, MI
A Study in Participants With Moderate to Severe Rheumatoid Arthritis
A Randomized, Double-Blind, Active-Controlled,Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib (LY3009104) in Patients With Moderately to Severely Active Rheumatoid Arthritis Who Have Had Limited or No Treatment With Disease-Modifying Antirheumatic Drugs
Status: Enrolling
Updated: 9/24/2015
Clinical Research Facility
mi
from
Lansing, MI
Click here to add this to my saved trials
A Study in Participants With Moderate to Severe Rheumatoid Arthritis
A Randomized, Double-Blind, Active-Controlled,Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib (LY3009104) in Patients With Moderately to Severely Active Rheumatoid Arthritis Who Have Had Limited or No Treatment With Disease-Modifying Antirheumatic Drugs
Status: Enrolling
Updated:  9/24/2015
Clinical Research Facility
mi
from
Flowood, MS
A Study in Participants With Moderate to Severe Rheumatoid Arthritis
A Randomized, Double-Blind, Active-Controlled,Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib (LY3009104) in Patients With Moderately to Severely Active Rheumatoid Arthritis Who Have Had Limited or No Treatment With Disease-Modifying Antirheumatic Drugs
Status: Enrolling
Updated: 9/24/2015
Clinical Research Facility
mi
from
Flowood, MS
Click here to add this to my saved trials
A Study in Participants With Moderate to Severe Rheumatoid Arthritis
A Randomized, Double-Blind, Active-Controlled,Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib (LY3009104) in Patients With Moderately to Severely Active Rheumatoid Arthritis Who Have Had Limited or No Treatment With Disease-Modifying Antirheumatic Drugs
Status: Enrolling
Updated:  9/24/2015
Clinical Research Facility
mi
from
St Louis, MO
A Study in Participants With Moderate to Severe Rheumatoid Arthritis
A Randomized, Double-Blind, Active-Controlled,Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib (LY3009104) in Patients With Moderately to Severely Active Rheumatoid Arthritis Who Have Had Limited or No Treatment With Disease-Modifying Antirheumatic Drugs
Status: Enrolling
Updated: 9/24/2015
Clinical Research Facility
mi
from
St Louis, MO
Click here to add this to my saved trials
A Study in Participants With Moderate to Severe Rheumatoid Arthritis
A Randomized, Double-Blind, Active-Controlled,Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib (LY3009104) in Patients With Moderately to Severely Active Rheumatoid Arthritis Who Have Had Limited or No Treatment With Disease-Modifying Antirheumatic Drugs
Status: Enrolling
Updated:  9/24/2015
Clinical Research Facility
mi
from
Freehold, NJ
A Study in Participants With Moderate to Severe Rheumatoid Arthritis
A Randomized, Double-Blind, Active-Controlled,Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib (LY3009104) in Patients With Moderately to Severely Active Rheumatoid Arthritis Who Have Had Limited or No Treatment With Disease-Modifying Antirheumatic Drugs
Status: Enrolling
Updated: 9/24/2015
Clinical Research Facility
mi
from
Freehold, NJ
Click here to add this to my saved trials
A Study in Participants With Moderate to Severe Rheumatoid Arthritis
A Randomized, Double-Blind, Active-Controlled,Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib (LY3009104) in Patients With Moderately to Severely Active Rheumatoid Arthritis Who Have Had Limited or No Treatment With Disease-Modifying Antirheumatic Drugs
Status: Enrolling
Updated:  9/24/2015
Clinical Research Facility
mi
from
Toms River, NJ
A Study in Participants With Moderate to Severe Rheumatoid Arthritis
A Randomized, Double-Blind, Active-Controlled,Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib (LY3009104) in Patients With Moderately to Severely Active Rheumatoid Arthritis Who Have Had Limited or No Treatment With Disease-Modifying Antirheumatic Drugs
Status: Enrolling
Updated: 9/24/2015
Clinical Research Facility
mi
from
Toms River, NJ
Click here to add this to my saved trials
A Study in Participants With Moderate to Severe Rheumatoid Arthritis
A Randomized, Double-Blind, Active-Controlled,Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib (LY3009104) in Patients With Moderately to Severely Active Rheumatoid Arthritis Who Have Had Limited or No Treatment With Disease-Modifying Antirheumatic Drugs
Status: Enrolling
Updated:  9/24/2015
Clinical Research Facility
mi
from
Albuquerque, NM
A Study in Participants With Moderate to Severe Rheumatoid Arthritis
A Randomized, Double-Blind, Active-Controlled,Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib (LY3009104) in Patients With Moderately to Severely Active Rheumatoid Arthritis Who Have Had Limited or No Treatment With Disease-Modifying Antirheumatic Drugs
Status: Enrolling
Updated: 9/24/2015
Clinical Research Facility
mi
from
Albuquerque, NM
Click here to add this to my saved trials
A Study in Participants With Moderate to Severe Rheumatoid Arthritis
A Randomized, Double-Blind, Active-Controlled,Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib (LY3009104) in Patients With Moderately to Severely Active Rheumatoid Arthritis Who Have Had Limited or No Treatment With Disease-Modifying Antirheumatic Drugs
Status: Enrolling
Updated:  9/24/2015
Clinical Research Facility
mi
from
Hartsdale, NY
A Study in Participants With Moderate to Severe Rheumatoid Arthritis
A Randomized, Double-Blind, Active-Controlled,Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib (LY3009104) in Patients With Moderately to Severely Active Rheumatoid Arthritis Who Have Had Limited or No Treatment With Disease-Modifying Antirheumatic Drugs
Status: Enrolling
Updated: 9/24/2015
Clinical Research Facility
mi
from
Hartsdale, NY
Click here to add this to my saved trials
A Study in Participants With Moderate to Severe Rheumatoid Arthritis
A Randomized, Double-Blind, Active-Controlled,Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib (LY3009104) in Patients With Moderately to Severely Active Rheumatoid Arthritis Who Have Had Limited or No Treatment With Disease-Modifying Antirheumatic Drugs
Status: Enrolling
Updated:  9/24/2015
Clinical Research Facility
mi
from
Middleburg Heights, OH
A Study in Participants With Moderate to Severe Rheumatoid Arthritis
A Randomized, Double-Blind, Active-Controlled,Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib (LY3009104) in Patients With Moderately to Severely Active Rheumatoid Arthritis Who Have Had Limited or No Treatment With Disease-Modifying Antirheumatic Drugs
Status: Enrolling
Updated: 9/24/2015
Clinical Research Facility
mi
from
Middleburg Heights, OH
Click here to add this to my saved trials
A Study in Participants With Moderate to Severe Rheumatoid Arthritis
A Randomized, Double-Blind, Active-Controlled,Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib (LY3009104) in Patients With Moderately to Severely Active Rheumatoid Arthritis Who Have Had Limited or No Treatment With Disease-Modifying Antirheumatic Drugs
Status: Enrolling
Updated:  9/24/2015
Clinical Research Facility
mi
from
Oklahoma City, OK
A Study in Participants With Moderate to Severe Rheumatoid Arthritis
A Randomized, Double-Blind, Active-Controlled,Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib (LY3009104) in Patients With Moderately to Severely Active Rheumatoid Arthritis Who Have Had Limited or No Treatment With Disease-Modifying Antirheumatic Drugs
Status: Enrolling
Updated: 9/24/2015
Clinical Research Facility
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
A Study in Participants With Moderate to Severe Rheumatoid Arthritis
A Randomized, Double-Blind, Active-Controlled,Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib (LY3009104) in Patients With Moderately to Severely Active Rheumatoid Arthritis Who Have Had Limited or No Treatment With Disease-Modifying Antirheumatic Drugs
Status: Enrolling
Updated:  9/24/2015
Clinical Research Facility
mi
from
Tulsa, OK
A Study in Participants With Moderate to Severe Rheumatoid Arthritis
A Randomized, Double-Blind, Active-Controlled,Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib (LY3009104) in Patients With Moderately to Severely Active Rheumatoid Arthritis Who Have Had Limited or No Treatment With Disease-Modifying Antirheumatic Drugs
Status: Enrolling
Updated: 9/24/2015
Clinical Research Facility
mi
from
Tulsa, OK
Click here to add this to my saved trials
A Study in Participants With Moderate to Severe Rheumatoid Arthritis
A Randomized, Double-Blind, Active-Controlled,Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib (LY3009104) in Patients With Moderately to Severely Active Rheumatoid Arthritis Who Have Had Limited or No Treatment With Disease-Modifying Antirheumatic Drugs
Status: Enrolling
Updated:  9/24/2015
Clinical Research Facility
mi
from
Portland, OR
A Study in Participants With Moderate to Severe Rheumatoid Arthritis
A Randomized, Double-Blind, Active-Controlled,Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib (LY3009104) in Patients With Moderately to Severely Active Rheumatoid Arthritis Who Have Had Limited or No Treatment With Disease-Modifying Antirheumatic Drugs
Status: Enrolling
Updated: 9/24/2015
Clinical Research Facility
mi
from
Portland, OR
Click here to add this to my saved trials
A Study in Participants With Moderate to Severe Rheumatoid Arthritis
A Randomized, Double-Blind, Active-Controlled,Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib (LY3009104) in Patients With Moderately to Severely Active Rheumatoid Arthritis Who Have Had Limited or No Treatment With Disease-Modifying Antirheumatic Drugs
Status: Enrolling
Updated:  9/24/2015
Clinical Research Facility
mi
from
Duncansville, PA
A Study in Participants With Moderate to Severe Rheumatoid Arthritis
A Randomized, Double-Blind, Active-Controlled,Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib (LY3009104) in Patients With Moderately to Severely Active Rheumatoid Arthritis Who Have Had Limited or No Treatment With Disease-Modifying Antirheumatic Drugs
Status: Enrolling
Updated: 9/24/2015
Clinical Research Facility
mi
from
Duncansville, PA
Click here to add this to my saved trials
A Study in Participants With Moderate to Severe Rheumatoid Arthritis
A Randomized, Double-Blind, Active-Controlled,Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib (LY3009104) in Patients With Moderately to Severely Active Rheumatoid Arthritis Who Have Had Limited or No Treatment With Disease-Modifying Antirheumatic Drugs
Status: Enrolling
Updated:  9/24/2015
Clinical Research Facility
mi
from
Wyomissing, PA
A Study in Participants With Moderate to Severe Rheumatoid Arthritis
A Randomized, Double-Blind, Active-Controlled,Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib (LY3009104) in Patients With Moderately to Severely Active Rheumatoid Arthritis Who Have Had Limited or No Treatment With Disease-Modifying Antirheumatic Drugs
Status: Enrolling
Updated: 9/24/2015
Clinical Research Facility
mi
from
Wyomissing, PA
Click here to add this to my saved trials
A Study in Participants With Moderate to Severe Rheumatoid Arthritis
A Randomized, Double-Blind, Active-Controlled,Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib (LY3009104) in Patients With Moderately to Severely Active Rheumatoid Arthritis Who Have Had Limited or No Treatment With Disease-Modifying Antirheumatic Drugs
Status: Enrolling
Updated:  9/24/2015
Clinical Research Facility
mi
from
Jackson, TN
A Study in Participants With Moderate to Severe Rheumatoid Arthritis
A Randomized, Double-Blind, Active-Controlled,Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib (LY3009104) in Patients With Moderately to Severely Active Rheumatoid Arthritis Who Have Had Limited or No Treatment With Disease-Modifying Antirheumatic Drugs
Status: Enrolling
Updated: 9/24/2015
Clinical Research Facility
mi
from
Jackson, TN
Click here to add this to my saved trials
A Study in Participants With Moderate to Severe Rheumatoid Arthritis
A Randomized, Double-Blind, Active-Controlled,Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib (LY3009104) in Patients With Moderately to Severely Active Rheumatoid Arthritis Who Have Had Limited or No Treatment With Disease-Modifying Antirheumatic Drugs
Status: Enrolling
Updated:  9/24/2015
Clinical Research Facility
mi
from
Dallas, TX
A Study in Participants With Moderate to Severe Rheumatoid Arthritis
A Randomized, Double-Blind, Active-Controlled,Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib (LY3009104) in Patients With Moderately to Severely Active Rheumatoid Arthritis Who Have Had Limited or No Treatment With Disease-Modifying Antirheumatic Drugs
Status: Enrolling
Updated: 9/24/2015
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
A Study in Participants With Moderate to Severe Rheumatoid Arthritis
A Randomized, Double-Blind, Active-Controlled,Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib (LY3009104) in Patients With Moderately to Severely Active Rheumatoid Arthritis Who Have Had Limited or No Treatment With Disease-Modifying Antirheumatic Drugs
Status: Enrolling
Updated:  9/24/2015
Clinical Research Facility
mi
from
Grapevine, TX
A Study in Participants With Moderate to Severe Rheumatoid Arthritis
A Randomized, Double-Blind, Active-Controlled,Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib (LY3009104) in Patients With Moderately to Severely Active Rheumatoid Arthritis Who Have Had Limited or No Treatment With Disease-Modifying Antirheumatic Drugs
Status: Enrolling
Updated: 9/24/2015
Clinical Research Facility
mi
from
Grapevine, TX
Click here to add this to my saved trials
A Study in Participants With Moderate to Severe Rheumatoid Arthritis
A Randomized, Double-Blind, Active-Controlled,Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib (LY3009104) in Patients With Moderately to Severely Active Rheumatoid Arthritis Who Have Had Limited or No Treatment With Disease-Modifying Antirheumatic Drugs
Status: Enrolling
Updated:  9/24/2015
Clinical Research Facility
mi
from
Houston, TX
A Study in Participants With Moderate to Severe Rheumatoid Arthritis
A Randomized, Double-Blind, Active-Controlled,Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib (LY3009104) in Patients With Moderately to Severely Active Rheumatoid Arthritis Who Have Had Limited or No Treatment With Disease-Modifying Antirheumatic Drugs
Status: Enrolling
Updated: 9/24/2015
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
A Study in Participants With Moderate to Severe Rheumatoid Arthritis
A Randomized, Double-Blind, Active-Controlled,Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib (LY3009104) in Patients With Moderately to Severely Active Rheumatoid Arthritis Who Have Had Limited or No Treatment With Disease-Modifying Antirheumatic Drugs
Status: Enrolling
Updated:  9/24/2015
Clinical Research Facility
mi
from
Lubbock, TX
A Study in Participants With Moderate to Severe Rheumatoid Arthritis
A Randomized, Double-Blind, Active-Controlled,Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib (LY3009104) in Patients With Moderately to Severely Active Rheumatoid Arthritis Who Have Had Limited or No Treatment With Disease-Modifying Antirheumatic Drugs
Status: Enrolling
Updated: 9/24/2015
Clinical Research Facility
mi
from
Lubbock, TX
Click here to add this to my saved trials
A Study in Participants With Moderate to Severe Rheumatoid Arthritis
A Randomized, Double-Blind, Active-Controlled,Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib (LY3009104) in Patients With Moderately to Severely Active Rheumatoid Arthritis Who Have Had Limited or No Treatment With Disease-Modifying Antirheumatic Drugs
Status: Enrolling
Updated:  9/24/2015
Clinical Research Facility
mi
from
Nassau Bay, TX
A Study in Participants With Moderate to Severe Rheumatoid Arthritis
A Randomized, Double-Blind, Active-Controlled,Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib (LY3009104) in Patients With Moderately to Severely Active Rheumatoid Arthritis Who Have Had Limited or No Treatment With Disease-Modifying Antirheumatic Drugs
Status: Enrolling
Updated: 9/24/2015
Clinical Research Facility
mi
from
Nassau Bay, TX
Click here to add this to my saved trials
A Study in Participants With Moderate to Severe Rheumatoid Arthritis
A Randomized, Double-Blind, Active-Controlled,Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib (LY3009104) in Patients With Moderately to Severely Active Rheumatoid Arthritis Who Have Had Limited or No Treatment With Disease-Modifying Antirheumatic Drugs
Status: Enrolling
Updated:  9/24/2015
Clinical Research Facility
mi
from
Chesapeake, VA
A Study in Participants With Moderate to Severe Rheumatoid Arthritis
A Randomized, Double-Blind, Active-Controlled,Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib (LY3009104) in Patients With Moderately to Severely Active Rheumatoid Arthritis Who Have Had Limited or No Treatment With Disease-Modifying Antirheumatic Drugs
Status: Enrolling
Updated: 9/24/2015
Clinical Research Facility
mi
from
Chesapeake, VA
Click here to add this to my saved trials
A Study in Participants With Moderate to Severe Rheumatoid Arthritis
A Randomized, Double-Blind, Active-Controlled,Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib (LY3009104) in Patients With Moderately to Severely Active Rheumatoid Arthritis Who Have Had Limited or No Treatment With Disease-Modifying Antirheumatic Drugs
Status: Enrolling
Updated:  9/24/2015
Clinical Research Facility
mi
from
Kennewick, WA
A Study in Participants With Moderate to Severe Rheumatoid Arthritis
A Randomized, Double-Blind, Active-Controlled,Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib (LY3009104) in Patients With Moderately to Severely Active Rheumatoid Arthritis Who Have Had Limited or No Treatment With Disease-Modifying Antirheumatic Drugs
Status: Enrolling
Updated: 9/24/2015
Clinical Research Facility
mi
from
Kennewick, WA
Click here to add this to my saved trials
A Study in Participants With Moderate to Severe Rheumatoid Arthritis
A Randomized, Double-Blind, Active-Controlled,Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib (LY3009104) in Patients With Moderately to Severely Active Rheumatoid Arthritis Who Have Had Limited or No Treatment With Disease-Modifying Antirheumatic Drugs
Status: Enrolling
Updated:  9/24/2015
Clinical Research Facility
mi
from
Vancouver, WA
A Study in Participants With Moderate to Severe Rheumatoid Arthritis
A Randomized, Double-Blind, Active-Controlled,Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib (LY3009104) in Patients With Moderately to Severely Active Rheumatoid Arthritis Who Have Had Limited or No Treatment With Disease-Modifying Antirheumatic Drugs
Status: Enrolling
Updated: 9/24/2015
Clinical Research Facility
mi
from
Vancouver, WA
Click here to add this to my saved trials
A Study in Participants With Moderate to Severe Rheumatoid Arthritis
A Randomized, Double-Blind, Active-Controlled,Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib (LY3009104) in Patients With Moderately to Severely Active Rheumatoid Arthritis Who Have Had Limited or No Treatment With Disease-Modifying Antirheumatic Drugs
Status: Enrolling
Updated:  9/24/2015
Clinical Research Facility
mi
from
Clarksburg, WV
A Study in Participants With Moderate to Severe Rheumatoid Arthritis
A Randomized, Double-Blind, Active-Controlled,Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib (LY3009104) in Patients With Moderately to Severely Active Rheumatoid Arthritis Who Have Had Limited or No Treatment With Disease-Modifying Antirheumatic Drugs
Status: Enrolling
Updated: 9/24/2015
Clinical Research Facility
mi
from
Clarksburg, WV
Click here to add this to my saved trials
A Study in Participants With Moderate to Severe Rheumatoid Arthritis
A Randomized, Double-Blind, Active-Controlled,Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib (LY3009104) in Patients With Moderately to Severely Active Rheumatoid Arthritis Who Have Had Limited or No Treatment With Disease-Modifying Antirheumatic Drugs
Status: Enrolling
Updated:  9/24/2015
Clinical Research Facility
mi
from
Franklin, WI
A Study in Participants With Moderate to Severe Rheumatoid Arthritis
A Randomized, Double-Blind, Active-Controlled,Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib (LY3009104) in Patients With Moderately to Severely Active Rheumatoid Arthritis Who Have Had Limited or No Treatment With Disease-Modifying Antirheumatic Drugs
Status: Enrolling
Updated: 9/24/2015
Clinical Research Facility
mi
from
Franklin, WI
Click here to add this to my saved trials
A Study in Participants With Moderate to Severe Rheumatoid Arthritis
A Randomized, Double-Blind, Active-Controlled,Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib (LY3009104) in Patients With Moderately to Severely Active Rheumatoid Arthritis Who Have Had Limited or No Treatment With Disease-Modifying Antirheumatic Drugs
Status: Enrolling
Updated:  9/24/2015
mi
from
Buenos Aires,
A Study in Participants With Moderate to Severe Rheumatoid Arthritis
A Randomized, Double-Blind, Active-Controlled,Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib (LY3009104) in Patients With Moderately to Severely Active Rheumatoid Arthritis Who Have Had Limited or No Treatment With Disease-Modifying Antirheumatic Drugs
Status: Enrolling
Updated: 9/24/2015
mi
from
Buenos Aires,
Click here to add this to my saved trials
Specimen Collection for Individuals With Lung Disease Associated With Rheumatoid Arthritis
Specimen Procurement for Individuals With Pulmonary Fibrosis Associated With Rheumatoid Arthritis
Status: Enrolling
Updated:  9/26/2015
Boston University
mi
from
Boston, MA
Specimen Collection for Individuals With Lung Disease Associated With Rheumatoid Arthritis
Specimen Procurement for Individuals With Pulmonary Fibrosis Associated With Rheumatoid Arthritis
Status: Enrolling
Updated: 9/26/2015
Boston University
mi
from
Boston, MA
Click here to add this to my saved trials
Identification of Genes Associated With Lung Disease in Patients With Rheumatoid Arthritis
Pulmonary Fibrosis Associated With Rheumatoid Arthritis: Identification of Genetic Polymorphisms
Status: Enrolling
Updated:  9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Identification of Genes Associated With Lung Disease in Patients With Rheumatoid Arthritis
Pulmonary Fibrosis Associated With Rheumatoid Arthritis: Identification of Genetic Polymorphisms
Status: Enrolling
Updated: 9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Determining How the Nervous System Processes Pain in Adults With Fibromyalgia
Imaging the Cognitive Modulation of Pain
Status: Enrolling
Updated:  10/1/2015
University of Wisconsin-Madison
mi
from
Madison, WI
Determining How the Nervous System Processes Pain in Adults With Fibromyalgia
Imaging the Cognitive Modulation of Pain
Status: Enrolling
Updated: 10/1/2015
University of Wisconsin-Madison
mi
from
Madison, WI
Click here to add this to my saved trials
A Study To Evaluate The Effects Of Celecoxib (Celebrex®) Or Naproxen On Blood Pressure In Pediatric Subjects
A Phase 4, 6-week, Randomized Double Blind, Multicenter, Active-controlled Trial To Evaluate The Effects Of Celecoxib (Celebrex) Or Naproxen On Blood Pressure In Pediatric Subjects With Juvenile Idiopathic Arthritis.
Status: Enrolling
Updated:  10/7/2015
Catalina Pointe Clinical Research
mi
from
Tucson, AZ
A Study To Evaluate The Effects Of Celecoxib (Celebrex®) Or Naproxen On Blood Pressure In Pediatric Subjects
A Phase 4, 6-week, Randomized Double Blind, Multicenter, Active-controlled Trial To Evaluate The Effects Of Celecoxib (Celebrex) Or Naproxen On Blood Pressure In Pediatric Subjects With Juvenile Idiopathic Arthritis.
Status: Enrolling
Updated: 10/7/2015
Catalina Pointe Clinical Research
mi
from
Tucson, AZ
Click here to add this to my saved trials
A Study To Evaluate The Effects Of Celecoxib (Celebrex®) Or Naproxen On Blood Pressure In Pediatric Subjects
A Phase 4, 6-week, Randomized Double Blind, Multicenter, Active-controlled Trial To Evaluate The Effects Of Celecoxib (Celebrex) Or Naproxen On Blood Pressure In Pediatric Subjects With Juvenile Idiopathic Arthritis.
Status: Enrolling
Updated:  10/7/2015
Arkansas Children's Hospital
mi
from
Little Rock, AR
A Study To Evaluate The Effects Of Celecoxib (Celebrex®) Or Naproxen On Blood Pressure In Pediatric Subjects
A Phase 4, 6-week, Randomized Double Blind, Multicenter, Active-controlled Trial To Evaluate The Effects Of Celecoxib (Celebrex) Or Naproxen On Blood Pressure In Pediatric Subjects With Juvenile Idiopathic Arthritis.
Status: Enrolling
Updated: 10/7/2015
Arkansas Children's Hospital
mi
from
Little Rock, AR
Click here to add this to my saved trials
A Study To Evaluate The Effects Of Celecoxib (Celebrex®) Or Naproxen On Blood Pressure In Pediatric Subjects
A Phase 4, 6-week, Randomized Double Blind, Multicenter, Active-controlled Trial To Evaluate The Effects Of Celecoxib (Celebrex) Or Naproxen On Blood Pressure In Pediatric Subjects With Juvenile Idiopathic Arthritis.
Status: Enrolling
Updated:  10/7/2015
Children's Hospital, San Diego
mi
from
San Diego, CA
A Study To Evaluate The Effects Of Celecoxib (Celebrex®) Or Naproxen On Blood Pressure In Pediatric Subjects
A Phase 4, 6-week, Randomized Double Blind, Multicenter, Active-controlled Trial To Evaluate The Effects Of Celecoxib (Celebrex) Or Naproxen On Blood Pressure In Pediatric Subjects With Juvenile Idiopathic Arthritis.
Status: Enrolling
Updated: 10/7/2015
Children's Hospital, San Diego
mi
from
San Diego, CA
Click here to add this to my saved trials
A Study To Evaluate The Effects Of Celecoxib (Celebrex®) Or Naproxen On Blood Pressure In Pediatric Subjects
A Phase 4, 6-week, Randomized Double Blind, Multicenter, Active-controlled Trial To Evaluate The Effects Of Celecoxib (Celebrex) Or Naproxen On Blood Pressure In Pediatric Subjects With Juvenile Idiopathic Arthritis.
Status: Enrolling
Updated:  10/7/2015
Connecticut Children's Medical Center
mi
from
Hartford, CT
A Study To Evaluate The Effects Of Celecoxib (Celebrex®) Or Naproxen On Blood Pressure In Pediatric Subjects
A Phase 4, 6-week, Randomized Double Blind, Multicenter, Active-controlled Trial To Evaluate The Effects Of Celecoxib (Celebrex) Or Naproxen On Blood Pressure In Pediatric Subjects With Juvenile Idiopathic Arthritis.
Status: Enrolling
Updated: 10/7/2015
Connecticut Children's Medical Center
mi
from
Hartford, CT
Click here to add this to my saved trials
A Study To Evaluate The Effects Of Celecoxib (Celebrex®) Or Naproxen On Blood Pressure In Pediatric Subjects
A Phase 4, 6-week, Randomized Double Blind, Multicenter, Active-controlled Trial To Evaluate The Effects Of Celecoxib (Celebrex) Or Naproxen On Blood Pressure In Pediatric Subjects With Juvenile Idiopathic Arthritis.
Status: Enrolling
Updated:  10/7/2015
Children's National Medical Center / Division of Rheumatology
mi
from
Washington,
A Study To Evaluate The Effects Of Celecoxib (Celebrex®) Or Naproxen On Blood Pressure In Pediatric Subjects
A Phase 4, 6-week, Randomized Double Blind, Multicenter, Active-controlled Trial To Evaluate The Effects Of Celecoxib (Celebrex) Or Naproxen On Blood Pressure In Pediatric Subjects With Juvenile Idiopathic Arthritis.
Status: Enrolling
Updated: 10/7/2015
Children's National Medical Center / Division of Rheumatology
mi
from
Washington,
Click here to add this to my saved trials
A Study To Evaluate The Effects Of Celecoxib (Celebrex®) Or Naproxen On Blood Pressure In Pediatric Subjects
A Phase 4, 6-week, Randomized Double Blind, Multicenter, Active-controlled Trial To Evaluate The Effects Of Celecoxib (Celebrex) Or Naproxen On Blood Pressure In Pediatric Subjects With Juvenile Idiopathic Arthritis.
Status: Enrolling
Updated:  10/7/2015
Arthritis Associates of South Florida
mi
from
Delray Beach, FL
A Study To Evaluate The Effects Of Celecoxib (Celebrex®) Or Naproxen On Blood Pressure In Pediatric Subjects
A Phase 4, 6-week, Randomized Double Blind, Multicenter, Active-controlled Trial To Evaluate The Effects Of Celecoxib (Celebrex) Or Naproxen On Blood Pressure In Pediatric Subjects With Juvenile Idiopathic Arthritis.
Status: Enrolling
Updated: 10/7/2015
Arthritis Associates of South Florida
mi
from
Delray Beach, FL
Click here to add this to my saved trials
A Study To Evaluate The Effects Of Celecoxib (Celebrex®) Or Naproxen On Blood Pressure In Pediatric Subjects
A Phase 4, 6-week, Randomized Double Blind, Multicenter, Active-controlled Trial To Evaluate The Effects Of Celecoxib (Celebrex) Or Naproxen On Blood Pressure In Pediatric Subjects With Juvenile Idiopathic Arthritis.
Status: Enrolling
Updated:  10/7/2015
Delray Research Associates
mi
from
Delray Beach, FL
A Study To Evaluate The Effects Of Celecoxib (Celebrex®) Or Naproxen On Blood Pressure In Pediatric Subjects
A Phase 4, 6-week, Randomized Double Blind, Multicenter, Active-controlled Trial To Evaluate The Effects Of Celecoxib (Celebrex) Or Naproxen On Blood Pressure In Pediatric Subjects With Juvenile Idiopathic Arthritis.
Status: Enrolling
Updated: 10/7/2015
Delray Research Associates
mi
from
Delray Beach, FL
Click here to add this to my saved trials
A Study To Evaluate The Effects Of Celecoxib (Celebrex®) Or Naproxen On Blood Pressure In Pediatric Subjects
A Phase 4, 6-week, Randomized Double Blind, Multicenter, Active-controlled Trial To Evaluate The Effects Of Celecoxib (Celebrex) Or Naproxen On Blood Pressure In Pediatric Subjects With Juvenile Idiopathic Arthritis.
Status: Enrolling
Updated:  10/7/2015
Miami Children's Hospital
mi
from
Miami, FL
A Study To Evaluate The Effects Of Celecoxib (Celebrex®) Or Naproxen On Blood Pressure In Pediatric Subjects
A Phase 4, 6-week, Randomized Double Blind, Multicenter, Active-controlled Trial To Evaluate The Effects Of Celecoxib (Celebrex) Or Naproxen On Blood Pressure In Pediatric Subjects With Juvenile Idiopathic Arthritis.
Status: Enrolling
Updated: 10/7/2015
Miami Children's Hospital
mi
from
Miami, FL
Click here to add this to my saved trials
A Study To Evaluate The Effects Of Celecoxib (Celebrex®) Or Naproxen On Blood Pressure In Pediatric Subjects
A Phase 4, 6-week, Randomized Double Blind, Multicenter, Active-controlled Trial To Evaluate The Effects Of Celecoxib (Celebrex) Or Naproxen On Blood Pressure In Pediatric Subjects With Juvenile Idiopathic Arthritis.
Status: Enrolling
Updated:  10/7/2015
Administrative Site-Hawaii Pacific Health Research Institute
mi
from
Honolulu, HI
A Study To Evaluate The Effects Of Celecoxib (Celebrex®) Or Naproxen On Blood Pressure In Pediatric Subjects
A Phase 4, 6-week, Randomized Double Blind, Multicenter, Active-controlled Trial To Evaluate The Effects Of Celecoxib (Celebrex) Or Naproxen On Blood Pressure In Pediatric Subjects With Juvenile Idiopathic Arthritis.
Status: Enrolling
Updated: 10/7/2015
Administrative Site-Hawaii Pacific Health Research Institute
mi
from
Honolulu, HI
Click here to add this to my saved trials
A Study To Evaluate The Effects Of Celecoxib (Celebrex®) Or Naproxen On Blood Pressure In Pediatric Subjects
A Phase 4, 6-week, Randomized Double Blind, Multicenter, Active-controlled Trial To Evaluate The Effects Of Celecoxib (Celebrex) Or Naproxen On Blood Pressure In Pediatric Subjects With Juvenile Idiopathic Arthritis.
Status: Enrolling
Updated:  10/7/2015
Kapiolani Medical Center for Women and Children
mi
from
Honolulu, HI
A Study To Evaluate The Effects Of Celecoxib (Celebrex®) Or Naproxen On Blood Pressure In Pediatric Subjects
A Phase 4, 6-week, Randomized Double Blind, Multicenter, Active-controlled Trial To Evaluate The Effects Of Celecoxib (Celebrex) Or Naproxen On Blood Pressure In Pediatric Subjects With Juvenile Idiopathic Arthritis.
Status: Enrolling
Updated: 10/7/2015
Kapiolani Medical Center for Women and Children
mi
from
Honolulu, HI
Click here to add this to my saved trials
A Study To Evaluate The Effects Of Celecoxib (Celebrex®) Or Naproxen On Blood Pressure In Pediatric Subjects
A Phase 4, 6-week, Randomized Double Blind, Multicenter, Active-controlled Trial To Evaluate The Effects Of Celecoxib (Celebrex) Or Naproxen On Blood Pressure In Pediatric Subjects With Juvenile Idiopathic Arthritis.
Status: Enrolling
Updated:  10/7/2015
Kosair Charities Pediatric Clinical Research Unit / University of Louisville
mi
from
Louisville, KY
A Study To Evaluate The Effects Of Celecoxib (Celebrex®) Or Naproxen On Blood Pressure In Pediatric Subjects
A Phase 4, 6-week, Randomized Double Blind, Multicenter, Active-controlled Trial To Evaluate The Effects Of Celecoxib (Celebrex) Or Naproxen On Blood Pressure In Pediatric Subjects With Juvenile Idiopathic Arthritis.
Status: Enrolling
Updated: 10/7/2015
Kosair Charities Pediatric Clinical Research Unit / University of Louisville
mi
from
Louisville, KY
Click here to add this to my saved trials
A Study To Evaluate The Effects Of Celecoxib (Celebrex®) Or Naproxen On Blood Pressure In Pediatric Subjects
A Phase 4, 6-week, Randomized Double Blind, Multicenter, Active-controlled Trial To Evaluate The Effects Of Celecoxib (Celebrex) Or Naproxen On Blood Pressure In Pediatric Subjects With Juvenile Idiopathic Arthritis.
Status: Enrolling
Updated:  10/7/2015
Kosair Children's Hospital
mi
from
Louisville, KY
A Study To Evaluate The Effects Of Celecoxib (Celebrex®) Or Naproxen On Blood Pressure In Pediatric Subjects
A Phase 4, 6-week, Randomized Double Blind, Multicenter, Active-controlled Trial To Evaluate The Effects Of Celecoxib (Celebrex) Or Naproxen On Blood Pressure In Pediatric Subjects With Juvenile Idiopathic Arthritis.
Status: Enrolling
Updated: 10/7/2015
Kosair Children's Hospital
mi
from
Louisville, KY
Click here to add this to my saved trials
A Study To Evaluate The Effects Of Celecoxib (Celebrex®) Or Naproxen On Blood Pressure In Pediatric Subjects
A Phase 4, 6-week, Randomized Double Blind, Multicenter, Active-controlled Trial To Evaluate The Effects Of Celecoxib (Celebrex) Or Naproxen On Blood Pressure In Pediatric Subjects With Juvenile Idiopathic Arthritis.
Status: Enrolling
Updated:  10/7/2015
University of Louisville
mi
from
Louisville, KY
A Study To Evaluate The Effects Of Celecoxib (Celebrex®) Or Naproxen On Blood Pressure In Pediatric Subjects
A Phase 4, 6-week, Randomized Double Blind, Multicenter, Active-controlled Trial To Evaluate The Effects Of Celecoxib (Celebrex) Or Naproxen On Blood Pressure In Pediatric Subjects With Juvenile Idiopathic Arthritis.
Status: Enrolling
Updated: 10/7/2015
University of Louisville
mi
from
Louisville, KY
Click here to add this to my saved trials
A Study To Evaluate The Effects Of Celecoxib (Celebrex®) Or Naproxen On Blood Pressure In Pediatric Subjects
A Phase 4, 6-week, Randomized Double Blind, Multicenter, Active-controlled Trial To Evaluate The Effects Of Celecoxib (Celebrex) Or Naproxen On Blood Pressure In Pediatric Subjects With Juvenile Idiopathic Arthritis.
Status: Enrolling
Updated:  10/7/2015
University Pediatric Rheumatology of Kentucky, LLC
mi
from
Louisville, KY
A Study To Evaluate The Effects Of Celecoxib (Celebrex®) Or Naproxen On Blood Pressure In Pediatric Subjects
A Phase 4, 6-week, Randomized Double Blind, Multicenter, Active-controlled Trial To Evaluate The Effects Of Celecoxib (Celebrex) Or Naproxen On Blood Pressure In Pediatric Subjects With Juvenile Idiopathic Arthritis.
Status: Enrolling
Updated: 10/7/2015
University Pediatric Rheumatology of Kentucky, LLC
mi
from
Louisville, KY
Click here to add this to my saved trials
A Study To Evaluate The Effects Of Celecoxib (Celebrex®) Or Naproxen On Blood Pressure In Pediatric Subjects
A Phase 4, 6-week, Randomized Double Blind, Multicenter, Active-controlled Trial To Evaluate The Effects Of Celecoxib (Celebrex) Or Naproxen On Blood Pressure In Pediatric Subjects With Juvenile Idiopathic Arthritis.
Status: Enrolling
Updated:  10/7/2015
Childrens Hospital & Medical Center
mi
from
Omaha, NE
A Study To Evaluate The Effects Of Celecoxib (Celebrex®) Or Naproxen On Blood Pressure In Pediatric Subjects
A Phase 4, 6-week, Randomized Double Blind, Multicenter, Active-controlled Trial To Evaluate The Effects Of Celecoxib (Celebrex) Or Naproxen On Blood Pressure In Pediatric Subjects With Juvenile Idiopathic Arthritis.
Status: Enrolling
Updated: 10/7/2015
Childrens Hospital & Medical Center
mi
from
Omaha, NE
Click here to add this to my saved trials